Germ Cell Testicular Tumors—Contemporary Diagnosis, Staging and Management of Localized and Advanced disease

Hanan Goldberg, Zachary Klaassen, Thenappan Chandrasekar, Neil Fleshner, Robert J. Hamilton, Michael A.S. Jewett

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

Germ cell testicular tumors are the most commonly diagnosed cancer in young men, with cure rates exceeding 95%. Clinical stage 1 disease is the most common manifestation, with radical orchiectomy curing the majority of Clinical stage 1 patients, making active surveillance the treatment of choice, with a cancer specific survival nearing 100% and low relapse rates. However, in metastatic disease, chemotherapy, radiotherapy, and surgery are curative options. Chemotherapy remains the mainstay of therapy for advanced disease with surgical management of residual disease. Patients with advanced disease should be treated in high volume experienced academic centers with multidisciplinary teams. Research exploring refinement of diagnosis and treatment, and lowering treatment burden is underway.

Original languageEnglish (US)
Pages (from-to)8-19
Number of pages12
JournalUrology
Volume125
DOIs
StatePublished - Mar 2019
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Germ Cell Testicular Tumors—Contemporary Diagnosis, Staging and Management of Localized and Advanced disease'. Together they form a unique fingerprint.

  • Cite this